From the Journals

New AHA statement on ischemia after cardiac surgery


 

FROM CIRCULATION

The American Heart Association outlines “considerations” on the management of acute postoperative myocardial ischemia (PMI) after cardiac surgery in a scientific statement.

Although an infrequent event, acute PMI following cardiac surgery can rapidly evolve and become a potentially life-threatening complication, the writing group, led by Mario Gaudino, MD, PhD, with Weill Cornell Medicine, New York, points out.

The new statement was published online in Circulation.

Data show that the incidence of postoperative myocardial infarction after cardiac surgery ranges from 0.3% to 9.8% after isolated coronary artery bypass graft (CABG) surgery and 0.7% to 11.8% after concomitant valvular surgery. For isolated mitral valve surgery, incidence ranges from 1.7% to 2.2%.

Short-term mortality is elevated among patients with acute PMI, irrespective of the type of surgery. Reported mortality rates range from 5.1% to 24%; the evidence on long-term mortality has been mixed.

Graft-related factors are the most common cause of PMI after CABG, but other factors may contribute, including technical factors, competitive flow, suture entrapment, or coronary artery distortion, as well as non–graft related factors.

Prompt diagnosis and treatment important

Currently, there is no consensus definition of PMI. Elevations in cardiac biomarkers may not be reliable for diagnosis after surgery, and pain management regimens may mask symptoms of ischemia, the writing group notes.

Given the difficulty in diagnosis, it’s important to maintain a “high index of suspicion for acute PMI in all patients undergoing cardiac surgery because timely diagnosis and treatment are key to a good clinical outcome,” they write.

Delay in urgent angiography has been associated with higher mortality; thus, a low threshold for action is encouraged for patients with suspected acute PMI.

Indications for urgent angiography include new ECG changes, chest pain with ongoing signs of ischemia, cardiac imaging abnormalities, cardiac rhythm abnormalities, significant elevations in cardiac biomarkers, and low cardiac output syndrome despite postoperative pressor support.

Patients with acute PMI and low cardiac output syndrome may require mechanical support when first-line treatment fails.

The writing group says fast and effective reperfusion of the ischemic zone, which is generally achieved by percutaneous intervention and, less often, by repeat surgery, is the key to a good clinical outcome.

The statement was prepared by the volunteer writing group on behalf of the AHA Council on Cardiovascular Surgery and Anesthesia; Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and Stroke Council.

The research had no commercial funding. Disclosures for the writing group are listed with the original article.

A version of this article originally appeared on Medscape.com.

Recommended Reading

Circulatory support for RV failure caused by pulmonary embolism
MDedge Cardiology
ECMO signals benefit for cardiogenic shock after MI in halted trial
MDedge Cardiology
Ticagrelor, DAPT equal in preventing repeat revascularization
MDedge Cardiology
Noncardiac mortality is not increased by revascularization in a meta-analysis: New data refute recent study
MDedge Cardiology
FDA class 1 recall for some Abiomed Impella heart pumps
MDedge Cardiology
Survival similar with hearts donated after circulatory or brain death
MDedge Cardiology
Support for minimally invasive mitral valve repair: Mini Mitral published
MDedge Cardiology
Hospital patient catches on fire, highlighting need for prevention
MDedge Cardiology
Interventional cardiologists worldwide burned out: Survey
MDedge Cardiology
TAVI turmoil: Did an ANP perform transcatheter aortic valve replacement in the U.K.?
MDedge Cardiology